ATORVALIQ
Active substance: atorvastatin
SUSPENSION · ATORVASTATIN CALCIUM TRIHYDRATE 20 mg/5mL
United StatesActive
Marketing holder: CMP Pharma, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- ATORVASTATIN CALCIUM TRIHYDRATE · 20 mg/5mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 104 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2951-739a-b7ef-7cb9cdd0ab0f,01a1208c-2ae6-791d-a567-5abecbc7daee,01a1208c-325b-7bde-9bff-04f7e28dd97e,01a1208c-367e-7c55-b4f2-3fc97cc44b72,01a1208c-369a-71e3-bcdd-2b326a81bdec;count=324 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 46287-030
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 46287-030 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 46287-030 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 46287-030 · Verified 2026-10-09 · open in source